| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 4e-05 |